{"id":"https://openalex.org/W30895175","doi":"https://doi.org/10.1002/cpt1974154424","title":"Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man","display_name":"Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man","publication_year":1974,"publication_date":"1974-04-01","ids":{"openalex":"https://openalex.org/W30895175","doi":"https://doi.org/10.1002/cpt1974154424","mag":"30895175","pmid":"https://pubmed.ncbi.nlm.nih.gov/4821443"},"language":"en","primary_location":{"id":"doi:10.1002/cpt1974154424","doi":"https://doi.org/10.1002/cpt1974154424","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cpt1974154424","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109559563","display_name":"A Breckenridge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315708478","display_name":"San Francisco VA Medical Center","ror":"https://ror.org/049peqw80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315708478","https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210125474","https://openalex.org/I4210143381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Breckenridge","raw_affiliation_strings":["M. R. C. Research Group in Clinical Pharmacology and Department of Clinical Pharmacology, Royal Postgraduate Medical School, and Veterans Administration Hospital, San Francisco, London, England, and San Francisco, Calif"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. R. C. Research Group in Clinical Pharmacology and Department of Clinical Pharmacology, Royal Postgraduate Medical School, and Veterans Administration Hospital, San Francisco, London, England, and San Francisco, Calif","institution_ids":["https://openalex.org/I1315708478"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110157946","display_name":"M. Orme","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315708478","display_name":"San Francisco VA Medical Center","ror":"https://ror.org/049peqw80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315708478","https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210125474","https://openalex.org/I4210143381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Orme","raw_affiliation_strings":["M. R. C. Research Group in Clinical Pharmacology and Department of Clinical Pharmacology, Royal Postgraduate Medical School, and Veterans Administration Hospital, San Francisco, London, England, and San Francisco, Calif"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. R. C. Research Group in Clinical Pharmacology and Department of Clinical Pharmacology, Royal Postgraduate Medical School, and Veterans Administration Hospital, San Francisco, London, England, and San Francisco, Calif","institution_ids":["https://openalex.org/I1315708478"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088191180","display_name":"H. Wesseling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315708478","display_name":"San Francisco VA Medical Center","ror":"https://ror.org/049peqw80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315708478","https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210125474","https://openalex.org/I4210143381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Wesseling","raw_affiliation_strings":["M. R. C. Research Group in Clinical Pharmacology and Department of Clinical Pharmacology, Royal Postgraduate Medical School, and Veterans Administration Hospital, San Francisco, London, England, and San Francisco, Calif"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. R. C. Research Group in Clinical Pharmacology and Department of Clinical Pharmacology, Royal Postgraduate Medical School, and Veterans Administration Hospital, San Francisco, London, England, and San Francisco, Calif","institution_ids":["https://openalex.org/I1315708478"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019949530","display_name":"R. J. Lewis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315708478","display_name":"San Francisco VA Medical Center","ror":"https://ror.org/049peqw80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315708478","https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210125474","https://openalex.org/I4210143381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. J. Lewis","raw_affiliation_strings":["M. R. C. Research Group in Clinical Pharmacology and Department of Clinical Pharmacology, Royal Postgraduate Medical School, and Veterans Administration Hospital, San Francisco, London, England, and San Francisco, Calif"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. R. C. Research Group in Clinical Pharmacology and Department of Clinical Pharmacology, Royal Postgraduate Medical School, and Veterans Administration Hospital, San Francisco, London, England, and San Francisco, Calif","institution_ids":["https://openalex.org/I1315708478"]}]},{"author_position":"last","author":{"id":null,"display_name":"R. Gibbons","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315708478","display_name":"San Francisco VA Medical Center","ror":"https://ror.org/049peqw80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315708478","https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210125474","https://openalex.org/I4210143381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Gibbons","raw_affiliation_strings":["M. R. C. Research Group in Clinical Pharmacology and Department of Clinical Pharmacology, Royal Postgraduate Medical School, and Veterans Administration Hospital, San Francisco, London, England, and San Francisco, Calif"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. R. C. Research Group in Clinical Pharmacology and Department of Clinical Pharmacology, Royal Postgraduate Medical School, and Veterans Administration Hospital, San Francisco, London, England, and San Francisco, Calif","institution_ids":["https://openalex.org/I1315708478"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1315708478"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":2.6223,"has_fulltext":false,"cited_by_count":262,"citation_normalized_percentile":{"value":0.88989247,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"15","issue":"4","first_page":"424","last_page":"430"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.8939999938011169},{"id":"https://openalex.org/keywords/enantiomers","display_name":"enantiomers","score":0.9309999942779541},{"id":"https://openalex.org/keywords/r-warfarin","display_name":"R-warfarin","score":0.9430000185966492},{"id":"https://openalex.org/keywords/s-warfarin","display_name":"S-warfarin","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.949999988079071},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9760000109672546},{"id":"https://openalex.org/keywords/plasma-half-life","display_name":"plasma half-life","score":0.8379999995231628},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.875},{"id":"https://openalex.org/keywords/plasma-clearance","display_name":"plasma clearance","score":0.9980000257492065},{"id":"https://openalex.org/keywords/anticoagulant-potency","display_name":"anticoagulant potency","score":0.9829999804496765},{"id":"https://openalex.org/keywords/enantiomeric-ratio","display_name":"enantiomeric ratio","score":0.6389999985694885},{"id":"https://openalex.org/keywords/dose-requirement","display_name":"dose requirement","score":0.5139999985694885},{"id":"https://openalex.org/keywords/repeated-dosing","display_name":"repeated dosing","score":0.5809999704360962},{"id":"https://openalex.org/keywords/oral-anticoagulants","display_name":"oral anticoagulants","score":0.6809999942779541}],"concepts":[{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.9360052347183228},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.7710863351821899},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7682210803031921},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7560057640075684},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.7077630162239075},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6152418255805969},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48901399970054626},{"id":"https://openalex.org/C486523","wikidata":"https://www.wikidata.org/wiki/Q494483","display_name":"Enantiomer","level":2,"score":0.43154558539390564},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39993295073509216},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39022621512413025},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3305628299713135},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21872836351394653},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.10182580351829529},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007536","descriptor_name":"Isomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013924","descriptor_name":"Thrombophlebitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/cpt1974154424","doi":"https://doi.org/10.1002/cpt1974154424","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cpt1974154424","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:4821443","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/4821443","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2001336191","https://openalex.org/W2413097882","https://openalex.org/W2155051931","https://openalex.org/W2411440399","https://openalex.org/W2113564693","https://openalex.org/W2053814596","https://openalex.org/W1712708601","https://openalex.org/W1992111447","https://openalex.org/W2041354145","https://openalex.org/W2355025094"],"abstract_inverted_index":{"The":[0,131,158,178,204],"rate":[1],"of":[2,6,14,17,31,39,54,73,75,83,91,103,121,134,136,147,155,161,165,180,185,201,208],"elimination,":[3],"apparent":[4,71,132],"volume":[5,72,133],"distribution,":[7],"plasma":[8,28,81,101,145,159,183],"clearance,":[9],"and":[10,48,78,115,142],"relative":[11,205],"anticoagulant":[12,202,226],"potency":[13],"the":[15,27,70,76,80,100,137,140,144,181,198],"enantiomers":[16,138],"warfarin":[18,33,85,105,189,212,221,229],"have":[19],"been":[20],"determined":[21],"in":[22,69,106,194,217,230],"man.":[23,231],"In":[24],"9":[25],"subjects":[26,108],"half\u2010life":[29],"(T\u00bd)":[30],"R":[32,84,104,148,162,186,209,228],"after":[34,170,174],"a":[35,175,223],"single":[36,176],"oral":[37],"dose":[38,206],"0.5":[40],"mg/kg":[41],"ranged":[42,58,109,125],"from":[43,59,110,126],"19.9":[44],"to":[45,61,97,112,128,187,210],"69.S":[46],"hours,":[47],"was":[49,65,86,116,139,149,167,190],"significantly":[50,87,117,151,168],"longer":[51,118,169],"than":[52,89,119,153,173,227],"that":[53,90,120,154],"S":[55,92,122,156,166,188,211,220],"warfarin,":[56,123],"which":[57,124],"18.0":[60],"34.1":[62],"hours.":[63,130],"There":[64],"no":[66],"significant":[67],"difference":[68],"distribution":[74,135],"enantiomers,":[77],"thus":[79,143],"clearance":[82,146],"less":[88,152],"warfarin.":[93,157],"After":[94],"multiple":[95,171],"dosing":[96,172],"steady":[98],"state,":[99],"T%":[102],"8":[107],"37.4":[111],"88.6":[113],"hours":[114],"21.2":[127],"42.6":[129],"same,":[141],"again":[150],"T\u00bd":[160],"but":[163],"not":[164],"dose.":[177],"ratio":[179],"steady\u2010state":[182],"concentration":[184],"3.80":[191],":":[192,215],"1":[193,216],"4":[195],"patients":[196],"with":[197],"same":[199],"degree":[200],"control.":[203],"requirements":[207],"were":[213],"1.5.9":[214],"these":[218],"sub;ects.":[219],"is":[222],"more":[224],"potent":[225]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}